Investigating how aging of the immune system affects Parkinson’s and Alzheimer’s diseases.
Immune System Aging in Parkinson’s and Alzheimer’s disease: Epigenetics, biologic aging, and heightened immune states in a population-based study
['FUNDING_CAREER'] · UNIVERSITY OF CALIFORNIA LOS ANGELES · NIH-11061087
This study is looking at how aging in the immune system might be connected to diseases like Parkinson’s and Alzheimer’s, and it’s for people who want to understand more about how these conditions develop over time.
Quick facts
| Phase | ['FUNDING_CAREER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF CALIFORNIA LOS ANGELES (nih funded) |
| Locations | 1 site (LOS ANGELES, UNITED STATES) |
| Trial ID | NIH-11061087 on ClinicalTrials.gov |
What this research studies
This research explores the relationship between immune system aging and neurodegenerative diseases like Parkinson’s and Alzheimer’s. By utilizing advanced technologies and statistical methods, the study aims to analyze biological markers related to immune aging in patients compared to healthy individuals. It will also examine how these markers correlate with the development of symptoms over time, providing insights into the biological processes involved in these diseases.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals diagnosed with Parkinson’s disease or Alzheimer’s disease-related dementia, as well as healthy controls for comparison.
Not a fit: Patients with other neurological disorders unrelated to aging or immune system function may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new strategies for early detection and treatment of Parkinson’s and Alzheimer’s diseases by targeting immune system aging.
How similar studies have performed: Previous research has shown promising results in understanding the role of immune system changes in neurodegenerative diseases, indicating that this approach has potential for success.
Where this research is happening
LOS ANGELES, UNITED STATES
- UNIVERSITY OF CALIFORNIA LOS ANGELES — LOS ANGELES, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: PAUL, KIMBERLY — UNIVERSITY OF CALIFORNIA LOS ANGELES
- Study coordinator: PAUL, KIMBERLY
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.